Evidence map›Paper›PMID 37308818›Full record

ArticleBMC genomics2023

Transcriptional profile of Trichomonas vaginalis in response to metronidazole.

Yiting Xie, Ping Zhong, Wei Guan, Yanqing Zhao, Shuguo Yang, Yan Shao, Jian Li

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 5 citations in OpenAlex.

  1. Discovery of thienopyrimidine analog G-18 as a novel anti-trichomonal agent.International journal for parasitology. Drugs and drug resistance · 2026
    Article
  2. Article
  3. bioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. A Multi-Omics Perspective onInternational journal of molecular sciences · 2025
    Review
  6. Targeting histone acetylation to overcome drug resistance in the parasitebioRxiv : the preprint server for biology · 2025
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yiting Xie *School of Basic Medical Science, Hubei University of Medicine, Shiyan, 442000, China.
Ping Zhong *School of Basic Medical Science, Hubei University of Medicine, Shiyan, 442000, China.
Wei GuanSchool of Basic Medical Science, Hubei University of Medicine, Shiyan, 442000, China.
Yanqing ZhaoSchool of Basic Medical Science, Hubei University of Medicine, Shiyan, 442000, China.
Shuguo YangSchool of Basic Medical Science, Hubei University of Medicine, Shiyan, 442000, China.
Yan ShaoDepartment of Outpatient, Taihe Hospital, Hubei University of Medicine, Shiyan, 442000, China. shaoyantaihe@163.com.
Jian LiSchool of Basic Medical Science, Hubei University of Medicine, Shiyan, 442000, China. yxlijian@163.com.
Hubei University of Medicine · CNTaihe Hospital · CN

Funding

Post-Graduates of Hubei University of Medicine 2018QDJZR17Principle Investigator Program of Hubei University of Medicine HBMUPI202101Research Project of Hubei Provincial Department of Education Q20192102
6 · The paper itself

Abstract

backgroundTrichomoniasis caused by Trichomonas vaginalis, combined with its complications, has long frequently damaged millions of human health. Metronidazole (MTZ) is the first choice for therapy. Therefore, a better understanding of its trichomonacidal process to ultimately reveal the global mechanism of action is indispensable. To take a step toward this goal, electron microscopy and RNA sequencing were performed to fully reveal the early changes in T. vaginalis at the cellular and transcriptome levels after treatment with MTZ in vitro.

resultsThe results showed that the morphology and subcellular structures of T. vaginalis underwent prominent alterations, characterized by a rough surface with bubbly protrusions, broken holes and deformed nuclei with decreased nuclear membranes, chromatin and organelles. The RNA-seq data revealed a total of 10,937 differentially expressed genes (DEGs), consisting of 4,978 upregulated and 5,959 downregulated genes. Most DEGs for the known MTZ activators, such as pyruvate:ferredoxin oxidoreductase (PFOR) and iron-sulfur binding domain, were significantly downregulated. However, genes for other possible alternative MTZ activators such as thioredoxin reductase, nitroreductase family proteins and flavodoxin-like fold family proteins, were dramatically stimulated. GO and KEGG analyses revealed that genes for basic vital activities, proteostasis, replication and repair were stimulated under MTZ stress, but those for DNA synthesis, more complicated life activities such as the cell cycle, motility, signaling and even virulence were significantly inhibited in T. vaginalis. Meanwhile, increased single nucleotide polymorphism (SNP) and insertions - deletions (indels) were stimulated by MTZ.

conclusionsThe current study reveals evident nuclear and cytomembrane damage and multiple variations in T. vaginalis at the transcriptional level. These data will offer a meaningful foundation for a deeper understanding of the MTZ trichomonacidal process and the transcriptional response of T. vaginalis to MTZ-induced stress or even cell death.

Indexed as

Trichomonas vaginalisCell CycleCell NucleusChromatinHumansMetronidazoleChromatinMetronidazoleDifferentially expressed genesElectron microscopyMechanism of actionMetronidazoleTranscriptomeTrichomonas vaginalis

Identifiers

PMID37308818
PMCPMC10262402
OpenAlexW4380322115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.